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Summary
Background and purpose: Premature ventricular complexes (PVCs) are frequently encountered
in healthy people. But the association between PVCs and cardiac events is not well estab-
lished in Japan. We investigated the association of PVCs and cardiac deaths in people without
cardiovascular disease in the Jichi Medical School (JMS) Cohort study.
Methods and subjects: We conducted a prospective cohort study in 12 districts in Japan as part
of the JMS cohort study. Baseline data were obtained between April 1992 and July 1995. We
excluded subjects who had myocardial infarction and stroke and those who had not received
12-lead electrocardiograms. Cox’s proportional hazard model was used to calculate the hazard
ratios (HRs) of cardiovascular mortality of subjects with PVCs, using subjects without PVCs as
reference.
Results: A total of 11,158 participants (4333 males and 6825 females) were analyzed. Partici-
pants were followed for an average of 11.9 years. PVCs were present in 1.4% of men and 1.1% of
women. There were 92 cardiac deaths (47 males and 45 females) during the follow-up period.
In crude cardiovascular mortality, HRs (95% conﬁdence interval [CI]) were 5.29 (1.64—17.0)
in males and 2.14 (0.29—15.5) in females. Age-adjusted HRs were 3.73 (1.16—12.0) and 0.98
(0.13—7.21), respectively. After further adjustment for body mass index, systolic blood pres-
sure, total cholesterol level, high-density lipoprotein-cholesterol, and blood glucose, HRs were
3.98 (1.21—13.0) and 0.95 (0.13—7.11), respectively.
Conclusions: We conclude that PVCs are a predictive factor for cardiac death in men without
structural heart disease.
© 2010 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
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ntroduction
remature ventricular complexes (PVCs) are frequently
bserved on standard 12-lead electrocardiograms in healthy
eople [1,2]. In patients with coronary heart disease, PVCs
ave been shown to be associated with a poor prognosis [3].
ut the clinical importance of PVCs remains controversial
n apparently healthy people. Kennedy et al. reported that
symptomatic patients with frequent or complex PVCs have
good prognosis [4]. In contrast, some prospective stud-
es reported that incidental detection of PVCs is associated
ith all-cause mortality, myocardial infarction, and death
ue to coronary artery disease. The Framingham Heart Study
emonstrated that men without coronary heart disease who
ad complex or frequent ventricular arrhythmias were at
ncreased risk for all-cause mortality (relative risk 2.30) and
he occurrence of myocardial infarction or death from coro-
ary heart disease (relative risk 2.12) [5]. The Copenhagen
olter Study also reported that the detection of PVCs is
n independent predictor of cardiovascular events (hazard
atio 2.6) [6].
In Japan, short-term 12-lead electrocardiogram is often
sed as a health care check to detect subclinical or clinical
eart disease. PVCs are encountered in many healthy peo-
le. But the association between the presence of PVCs and
ardiac events is not well established in Japan.
The Jichi Medical School (JMS) Cohort study is a large
opulation-based prospective cohort study undertaken to
larify the risk factors for cardiovascular and cerebrovas-
ular disease in Japan [7]. Thus, we investigated the
ssociation of PVCs and cardiac deaths in subjects without
ardiovascular disease in this JMS cohort study.
ethods
ata were obtained between April 1992 and July 1995 in 12
istricts in rural areas of Japan as part of the JMS cohort
tudy. Mass screening for cardiovascular disease has been
onducted in Japan since 1983 in accordance with health
nd medical service law for the aged, and we used this sys-
em to collect data for this study. The study design and some
escriptive data have been presented previously [7]. The
articipants of this study were 12490 males and females.
ast history of myocardial infarction and stroke was exam-
ned by questionnaire. If participants had a past history of
hese diseases, they were excluded. But drug use at base-
ine was not assessed. We also excluded participants who
ad not received 12-lead electrocardiograms at baseline. As
result, 11,158 participants (4333 males and 6825 females)
ere enrolled in the present study. The Institutional Review
oard of Jichi Medical University of Medicine approved this
tudy and written informed consent was obtained from all
ubjects.
Electrocardiograms were measured at a paper speed of
5mm/s, at a gain of 10mm/mV, using electrocardiographic
evices that the institutes had (FCP130-A9, FCP145-M4, and
CP270-M5, Fukuda Denshi, Tokyo, Japan). An experienced
ardiologist, who did not know the subjects’ background,
ead the electrocardiographic ﬁndings independently. Body
ass index was calculated as weight (kg) divided by the
quare of body height (m).
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Systolic blood pressure was measured with a fully
utomated sphygmomanometer, BP203RV-II (Nippon Colin,
omaki, Japan), placed on the right arm of the subjects who
ad rested while seated for 5min before measurement.
Information about medical history and lifestyle was
btained by a questionnaire.
Total cholesterol levels were measured by enzymatic
ethods (Wako, Osaka, Japan; inter-assay CV: 1.5%). High-
ensity lipoprotein-cholesterol (HDL-C) was measured using
he phosphotungstate precipitation method (Wako; inter-
ssay CV: 1.9%). Blood glucose was measured via an
nzymatic method (Kanto Chemistry, Tokyo, Japan; inter-
ssay CV: 1.9%).
Causes of death were identiﬁed with death certiﬁcates,
hich were collected at respective local public centers with
ermission from the Ministry of General Affairs and the Min-
stry of Health, Labor and Welfare.
Repeat examinations were used to follow most subjects
very year. Those examined were asked whether they had
ny history of stroke and cardiovascular disease.
tatistical analysis
ll statistical analyses were performed on a personal com-
uter with the Statistical Package for Social Science® (SPSS)
or Windows (SPSS Japan Inc., version 11.5, Tokyo, Japan).
ata are expressed as mean± standard deviation (SD).
Cox’s proportional hazard models were used to calculate
he hazard ratios (HRs) of cardiovascular mortality adjusted
or age, body mass index, systolic blood pressure, total
holesterol level, HDL-cholesterol, and blood glucose.
A p-value less than 0.05 was considered to indicate sta-
istical signiﬁcance.
esults
total of 11,158 participants (4333 males and 6825 females)
ere analyzed in this study. Table 1 presents a comparison
f baseline characteristics for those with and without PVCs.
articipants were followed for an average of 11.9 years from
he time of baseline measurement until cardiac death. PVCs
ere present in 1.4% of men and 1.1% in women. Age in
oth sexes and systolic blood pressure in females were sig-
iﬁcantly higher in the PVCs group than in the non-PVCs
roup. Body mass index, total cholesterol, HDL-cholesterol,
nd blood glucose in both sexes and systolic blood pressure
n males were similar in both groups.
There were 92 cardiac deaths (47 males and 45 females)
uring the follow-up period. Table 2 shows HRs calculated by
ox’s proportional hazard models with patients with PVCs,
sing patients without PVCs as reference. Crude cardiac
ortality is 0.92/1000 person-year in males and 0.56 in
emales. In crude cardiovascular mortality, HRs with PVCs
95% conﬁdence interval [CI]) were 5.29 (1.64—17.0) in
ales and 2.14 (0.29—15.5) in females. Age-adjusted HRs
ere 3.73 (1.16—12.0) and 0.98 (0.13—7.21), respectively.
fter further adjustment for body mass index, systolic blood
ressure, total cholesterol level, HDL-cholesterol, and blood
lucose, HRs were 3.98 (1.21—13.0) and 0.95 (0.13—7.11),
espectively.
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Table 1 Baseline characteristics for those with and without PVC.
Males Females
Any PVC No PVC p-Value Any PVC No PVC p-Value
n (%) 59 (1.4%) 4274 (98.6%) N.S. 74 (1.1%) 6751 (98.9%) N.S.
Age (years) 60.0± 9.3 54.8± 12.0 <0.001 59.2± 11.3 55.1± 11.2 0.002
Body mass index (kg/m2) 22.9± 3.2 22.9± 2.9 N.S. 23.5± 3.3 23.1± 3.2 N.S.
SBP (mmHg) 135.1± 20.3 131.0± 20.4 N.S. 133± 23.9 127± 21.0 0.02
TC (mg/dl) 179± 31.6 185± 34.3 N.S. 195± 36.2 196± 34.8 N.S.
HDL-C (mg/dl) 47.4± 12.8 48.9± 13.4 N.S. 51.7± 12.9 52.8± 12.5 N.S.
BG (mg/dl) 111± 31.3 105± 30.7 N.S. 102± 30.6 100± 22.3 N.S.
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and complex PVCs); SBP, systolic blood pressure; TC, total cholest
Discussion
Our study demonstrates that apparently healthy men with
PVCs had signiﬁcantly increased cardiac mortality compared
with participants without PVCs in this cohort study. Few
reports have mentioned the association between PVCs and
cardiac deaths in Japan, although the Niigata preventive
medicine study reported PVC as risk factor of atrial ﬁbril-
lation [8]. Our study also demonstrates that screening of
PVCs on electrocardiograms may be beneﬁcial for detecting
individuals who are at high risk for cardiac death.
Our results are consistent with some other reports. The
Framingham Heart Study, which examined a large free-living
population, showed that menwithout coronary heart disease
who had complex or frequent ventricular arrhythmias were
at increased risk for all-cause mortality (relative risk 2.30)
and the occurrence of myocardial infarction or death from
coronary heart disease (relative risk 2.12) [5]. The Copen-
hagen Holter Study also reported that the detection of PVCs
was an independent predictor of cardiovascular events (haz-
ard ratio 2.6) [6]. A subanalysis of the Multiple Risk Factor
Intervention Trial (MRFIT) noted that the ﬁnding of any VPCs
on a 2-min rhythm strip, which was present in 4.4% of over
15,000 apparently healthy white men, was independently
associated with a threefold increase in sudden cardiac death
at seven year follow-up [9]. On the other hand, Kennedy
et al. investigated the prognostic importance of complex
or frequent ventricular arrhythmias in apparently healthy
people. They reported no increase in all-cause mortality or
myocardial infarction or death from coronary heart disease
in people without coronary heart disease who had complex
or frequent arrhythmias [4].
PVCs increased cardiac mortality in men, but not in
women in our study. Pathophysiology of gender differences
a
p
a
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Table 2 Relationship of premature ventricular complexes and ca
Male
Crude HR 5.29
Age-adjusted HR 3.73
Covariate adjusted HR 3.98
Data are expressed as hazard ratio (HR) (95% conﬁdence interval). Cov
cholesterol level, high-density lipoprotein-cholesterol, and blood gluco. PVC, premature ventricular complex (includes single, frequent,
HDL-C, high-density lipoprotein-cholesterol; BG, blood glucose.
ith respect to association between PVCs and cardiac mor-
ality is not well known. One possible speculation is that
he difference arises from sex differences in prevalence of
eft ventricular hypertrophy. Several previous studies have
hown that left ventricular hypertrophy is an important
isk factor for cardiovascular disease morbidity and mortal-
ty [10—14]. Bikkina et al. reported that in subjects with
eft ventricular hypertrophy, the presence of asymptomatic
entricular arrhythmia was associated with higher mortal-
ty [13] and a previous study reported that weight-adjusted
eft ventricular mass was greater in males than in females
14]. Thus, we speculate that the gender difference was
reﬂection of silent myocardial hypertrophy, although the
chocardiogram was not demonstrated at baseline.
In Japan, short-term 12-lead electrocardiogram is often
erformed in health care check-ups. PVCs are common ﬁnd-
ngs and occur in a broad spectrum of the population,
ncluding those without and with structural heart disease,
rrespective of its severity.
With our results, doctors or public health nurses may
nform people with PVCs of their increased risk. In the past,
iving advice to patients with PVCs without structural heart
isease has been difﬁcult. But no evidence exists that antiar-
hythmic therapy in patients with asymptomatic ventricular
rrhythmias improves cardiac mortality. Further investiga-
ion is needed to determine whether intervention is needed
or healthy people with PVCs.
The present study has several limitations. First, the
umber of patients with PVCs is small, due to short-term
easurement of electrocardiogram. Risk stratiﬁcation, such
s bigeminy, trigeminy, or frequency, was important in the
oint of cardiac death [15,16], but not demonstrated in this
nalysis. However, the sample size was still sufﬁcient to
emonstrate a statistical difference. Second, drug use at
rdiac death.
Female
(1.64—17.0) 2.14 (0.29—15.5)
(1.16—12.0) 0.98 (0.13—7.21)
(1.21—13.0) 0.95 (0.13—7.11)
ariates included body mass index, systolic blood pressure, total
se.
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aseline was not assessed. Triggered activity is a more com-
on mechanism for PVCs and such electrical activity may
rise because of drug toxicity (such as digoxin, diuretics, or
eta blockers) [17,18]. To our knowledge, there has been no
tudy that has reported PVCs association with drug use, such
s beta blocker and diuretics, in the general population. But
n Japan, these drugs are less commonly prescribed than
alcium channel blockers, angiotensin-converting enzyme
nhibitors, or angiotensin receptor blockers [19]. So we
elieve the effect of these drugs was small in our analy-
is. Third, variants of PVCs, i.e. monofocal or multifocal,
r couplets/runs was not considered, because of the small
ample size of multifocal, or couplets/runs.
This study was performed in Japanese subjects without
nown heart disease. We conclude that PVCs are a predic-
ive factor for cardiac death in men without structural heart
isease.
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